Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD). Since there are no clinical veri on administration of sildenafil to patients with veno-occlusive disease, administration of sildenafil to such patients is hami? recomme